Clinical Trial Update: Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical trial evaluating the efficacy and safety of OraVescent Fentanyl Citrate for breakthrough pain in opioid-tolerant patients with nonc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• OraVescent Fentanyl Citrate (fentanyl citrate)

Snippet

Sponsor: Cephalon | Conditions: Pain | Phase 3 | Status: COMPLETED